15 Oct

Pharmaceutical Solutions: Quality Assurance in Clinical Trials

With international travel restrictions in place, many pharmaceutical/biotech/CRO companies have had to place quality assurance audits for their clinical trials on hold. Pharmaceutical Solutions can help. Our highly experienced team delivers Quality Assurance services throughout Australia and New Zealand.

Our internationally IAOCR[1]-accredited Quality Assurance (QA) auditors provide a full range of independent quality assurance services. Our accredited auditors have vast experience in clinical research and can provide you with the following audit services across Australia and New Zealand for your next clinical trial:

  • Investigator Site Audits
  • Vendor Audits
  • Quality System Audits

Contact us to discuss how our QA team can help you achieve quality oversight for your next clinical trial.

--

[1] International Accrediting Organization for Clinical Research

Other News

HiRO – our global advantage, tailored solutions and key partnerships

Last year we announced that PharmaSols was acquired by global CRO, Harvest Integrated Research Organisation (HiRO) – recently announced as the Top CRO in the APAC region. Through HiRO, we were able to offer a larger global network, stronger leadership and investment in market-leading integrated systems and processes.

Read more
HiRO – an emerging full-service global CRO

Last year we announced that PharmaSols was acquired by global CRO, Harvest Integrated Research Organisation (HiRO). This meant we were able to offer a larger global network, stronger leadership and investment in market-leading integrated systems and processes. This month we will discuss a bit more about our parent company HiRO – their values, vision, service offerings, partnerships, and end-to-end specialised clinical trial solutions.

Read more
HiRO – Top CRO in APAC 2022

The world is witnessing an enormous demand for innovative medicines to manage and cure diseases. Despite the explosive record demand levels and best efforts of pharma companies during the COVID-19 pandemic, there is still uncertainty regarding the fastest approval process defined by the FDA.

Read more